News
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
OncologyLive
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Subscribe
Print Subscription
eNewsletter

logo
Spotlight
OncClub: Join the Chat on Trending Trials in Cancer
In-person and virtual events just for HCPs
Specialty
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
OncClub
All Oncology News
Pipeline Report
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conference Coverage
Conference Listing
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
OncologyLive
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Interactive Tools
Learning Modules
Presentations
Sponsored
Print Subscription
eNewsletter
Advertisement
Urothelial Cancer
| Breast Cancer
| Lung Cancer
| Gastrointestinal Cancer
| Genitourinary Cancers
| Ovarian Cancer
| Prostate Cancer
| Melanoma & Skin Cancer
| Mantle Cell Lymphoma
| Myeloproliferative Neoplasms
| Biosimilars
| Brain Cancer
| Business Management
| CAR T-cell Therapy
| COVID-19
| Chronic Lymphocytic Leukemia
| Colorectal Cancer
| Disparities in Cancer Care
| Global Oncology
| Gynecologic Oncology
| Head & Neck Cancers
| Hematologic Oncology
| Immuno-Oncology
| Multiple Myeloma
| Neoadjuvant HER2+
| Non-Hodgkin Lymphoma
| Oncology Nursing News
| Pediatric Oncology
| Precision Medicine in Oncology®
| Sarcomas/TGCT
| Supportive Care
View All >>
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
  • Business Management
  • CAR T-cell Therapy
  • COVID-19
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Global Oncology
  • Gynecologic Oncology
  • Head & Neck Cancers
  • Hematologic Oncology
  • Immuno-Oncology
  • Lung Cancer
  • Mantle Cell Lymphoma
  • Melanoma & Skin Cancer
  • Multiple Myeloma
  • Myeloproliferative Neoplasms
  • Neoadjuvant HER2+
  • Non-Hodgkin Lymphoma
  • Oncology Nursing News
  • Ovarian Cancer
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Prostate Cancer
  • Sarcomas/TGCT
  • Supportive Care
  • Urothelial Cancer

SPOTLIGHT -

OncClub: Join the Chat on Trending Trials in Cancer
| In-person and virtual events just for HCPs

Metastatic Melanoma: The New Millennium

home / peer-exchange / advances-in-melanoma
Systemic Therapy with T-VEC in Advanced Melanoma

EP. 1: Systemic Therapy with T-VEC in Advanced Melanoma

December 16th 2015
Practical Application of T-VEC in Melanoma Treatment

EP. 2: Practical Application of T-VEC in Melanoma Treatment

December 16th 2015
Radiation Therapy and Abscopal Effect in Melanoma Treatment

EP. 3: Radiation Therapy and Abscopal Effect in Melanoma Treatment

December 16th 2015
Role of Surgery in the Management of Advanced Melanoma

EP. 4: Role of Surgery in the Management of Advanced Melanoma

December 16th 2015
Use of Immunotherapy Agents in Melanoma Treatment

EP. 5: Use of Immunotherapy Agents in Melanoma Treatment

December 16th 2015
Sequencing of Checkpoint Agents in Melanoma

EP. 6: Sequencing of Checkpoint Agents in Melanoma

December 16th 2015
Duration of Immunotherapy in Melanoma

EP. 7: Duration of Immunotherapy in Melanoma

December 16th 2015
Checkpoint Inhibitors: Combination Therapy in Melanoma

EP. 8: Checkpoint Inhibitors: Combination Therapy in Melanoma

December 16th 2015
Combination Immunotherapy Treatment Duration in Melanoma Patients

EP. 9: Combination Immunotherapy Treatment Duration in Melanoma Patients

December 16th 2015
Treatment of BRAF-Mutant Metastatic Melanoma

EP. 10: Treatment of BRAF-Mutant Metastatic Melanoma

December 16th 2015
Sequencing Dual BRAF-MEK Inhibition and Immunotherapy

EP. 11: Sequencing Dual BRAF-MEK Inhibition and Immunotherapy

December 16th 2015
Duration of Dual BRAF-MEK Inhibition in Melanoma

EP. 12: Duration of Dual BRAF-MEK Inhibition in Melanoma

December 16th 2015
Hot Versus Cold Tumors: Predictive Markers in Melanoma

EP. 13: Hot Versus Cold Tumors: Predictive Markers in Melanoma

December 16th 2015
Future Advances in Melanoma Treatment

EP. 14: Future Advances in Melanoma Treatment

December 16th 2015

Latest Conference Coverage

Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors

Navigating Systemic Therapy for RCC: Balancing Risk Status and Response

ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC

Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact